WEXI Trademark

Trademark Overview


On Tuesday, July 1, 2025, a trademark application was filed for WEXI with the United States Patent and Trademark Office. The USPTO has given the WEXI trademark a serial number of 99262451. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, December 5, 2025. This trademark is owned by Mediscope Health Group LLC F.Z. The WEXI trademark is filed in the Pharmaceutical Products category with the following description:

Anti-diabetic pharmaceuticals
wexi

General Information


Serial Number99262451
Word MarkWEXI
Filing DateTuesday, July 1, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, December 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-diabetic pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 1, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMediscope Health Group LLC F.Z
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPembina, ND 58271

Trademark Events


Event DateEvent Description
Tuesday, July 1, 2025NEW APPLICATION ENTERED
Tuesday, July 1, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 1, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, November 19, 2025ASSIGNED TO EXAMINER
Friday, December 5, 2025NON-FINAL ACTION WRITTEN
Friday, December 5, 2025NON-FINAL ACTION E-MAILED
Friday, December 5, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords


wexi pharmaceuticals diabetic anti